missing translation for 'onlineSavingsMsg'
Learn More
Learn More
enQuireBio™ Recombinant Rat Semaphorin 3A / SEMA3A Protein
A DNA sequence encoding the Rattus norvegicus (Rat) Semaphorin 3A / SEMA3A, was expressed in the hosts and tags indicated.
€ 245.00 - € 3405.00
Specifications
Accession Number | NP_059006.1 |
---|---|
Gene ID (Entrez) | 29751 |
Name | Semaphorin 3A / SEMA3A Protein |
Regulatory Status | Research Use Only |
Endotoxin Concentration | Not determined. |
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
16020221
|
enQuireBio™
QP7692-EC-100UG |
100 μg |
€ 770.00
100µg |
Estimated Shipment: 21-06-2024 Log in to see stock. |
Please sign in to purchase this item. Need a web account? Register with us today! | ||||
16040221
|
enQuireBio™
QP7692-EC-1MG |
1 mg |
€ 3405.00
1mg |
Estimated Shipment: 21-06-2024 Log in to see stock. |
Please sign in to purchase this item. Need a web account? Register with us today! | ||||
16030221
|
enQuireBio™
QP7692-EC-10UG |
10 μg |
This item is currently unavailable or has been discontinued. View the product page for possible alternatives. |
||||||
16050221
|
enQuireBio™
QP7692-EC-200UG |
200 μg |
This item is currently unavailable or has been discontinued. View the product page for possible alternatives. |
||||||
16060221
|
enQuireBio™
QP7692-EC-500UG |
500 μg |
This item is currently unavailable or has been discontinued. View the product page for possible alternatives. |
||||||
16070221
|
enQuireBio™
QP7692-EC-50UG |
50 μg |
This item is currently unavailable or has been discontinued. View the product page for possible alternatives. |
||||||
Specifications
NP_059006.1 | |
Semaphorin 3A / SEMA3A Protein | |
Not determined. | |
Full Length | |
Rat | |
His | |
Tris-based buffer, 50% glycerol |
29751 | |
Research Use Only | |
Sema3a | |
Recombinant Protein | |
E. coli | |
YANGKNNVPR LKLSYKEMLE SNNVITFNGL ANSSSYHTFL LDEERSRLYV GAKDHIFSFN LVNIKDFQKI VWPVSYTRRD ECKWAGKDIL KECANFIKVL KAYNQTHLYA CGTGAFHPIC TYIEVGHHPE DNIFKLQDSH FENGRGKSPY DPKLLTASLL IDGELYSGTA ADFMGRDFAI FRTLGHHHPI RTEQHDSRWL NDPRFISAHL IPESDNPEDD KVYFFFRENA IDGEHSGKAT HARIGQICKN DFGGHRSLVN KWTTFLKARL ICSVPGPNGI DTHFDELQDV FLMNSKDPKN PIVYGVFTTS SNIFKGSAVC MYSMSDVRRV FLGPYAHRDG PNYQWVPYQG RVPYPRPGTC PSKTFGGFDS TKDLPDDVIT FARSHPAMYN PVFPINNRPI MIKTDVNYQF TQIVVDRVDA EDGQYDVMFI GTDVGTVLKV VSVPKETWHD LEEVLLEEMT VFREPTTISA MELSTKQQQL YIGSTAGVAQ LPLHRCDIYG KACAECCLAR DPYCAWDGSS CSRYFPTAKR RTRRQDIRNG DPLTHCSDLQ HHDNHHGHSL EERIIYGVEN SSTFLECSPK SQRALVYWQF QRRNEDRKEE IRVGDHIIRT EQGLLLRSLQ KKDSGNYLCH AVEHGFMQTL LKVTLEVIDT EHLEELLHKD DDGDGSKTKE MSSSMTPSQK VWYRDFMQLI NHPNLNTMDE FCEQVWKRDR KQRRQRPGHS QGSSNKWKHM QESKKGRNRR THEFERAPRS V | |
Greater than 90% as determined by SDS-PAGE. |